CHINATRIALS 14 Summit Advisory Board

James Cai
Vice President, Global Drug Development & Head of China R&D
BRISTOL-MYERS SQUIBB
Jianqing Chang
Vice President, Drug Regulatory Policy
TIGERMED
Feng Chen
Professor of Statistics & Dean of Graduate School
NANJING MEDICAL UNIVERSITY
Jessie Chen
Head of Development China, General Manager of China R&D
PFIZER
PJ Chen
Co-Founder & Chief Executive Officer
CALI BIOSCIENCES
Jing He
Senior Vice President, Head of China R&D
ASTRAZENECA
Ye Hua
Chairman & Chief Executive Officer
BIONOVA PHARMACEUTICALS
Min Irwin
Chief Executive Officer
REISTONE BIOPHARMA
Frank Jiang
Senior Advisor
CSTONE PHARMA
Helen Jiang
Chief Medical Officer
ZHEJIANG YANGSHENGTANG BIOTECH
Michael Jiang
Head of Strategic Initiatives & Scientific Relations China
SANOFI
Simon Li
Chief Executive Officer & Chief Medical Officer / Vice President
EVIVE BIOPHARMACEUTICAL / YIFAN PHARMA
Bin Peng
Chief Medical Officer
EPIMAB BIOTHERAPEUTICS
Wenru Song
Co-Founder & President of R&D
KIRA PHARMACEUTICALS
Jonathan Wang
Chairman & Chief Executive Officer
INMAGENE BIOPHARMACEUTICALS
Li Wang
Senior Vice President, Head of Drug Development & Medical Affairs Center
ELI LILLY & COMPANY
Lin Wang
Vice President, Global R&D Regional and Business Operations / Head of Development Center Asia
TAKEDA
Jielai Xia
Director, Health Statistics
AIR FORCE MEDICAL UNIVERSITY
Chen Yao
Director, Medical Statistics
PEKING UNIVERSITY FIRST HOSPITAL
Wei Zhang
Head of Medicine and R&D, Greater China
BOEHRINGER INGELHEIM